Model
Edge
Eagle Pharmaceuticals, Inc.
EGRX
Filing type
8-K
Filing date
Aug 26, 2024
Updated
Aug 27, 2024 ยท 2:30 PM
Copy reference
Filing
8-K
Material Contracts, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Reg. FD
Exhibits
EX-10.1
EXHIBIT 10.1
EX-99.1
Material Contracts, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Reg. FD
GRAPHIC
Graphic